StonvexLoading…
StonvexStonvexStonvexCore line items from TCRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.00K | $10.00K | $5.00K | $2.92M |
Operating Income | $-4.22M | $-4.81M | $-34.27M | $-35.10M |
Net Income | $-4.18M | $-4.68M | $-4.68M | $-37.73M |
EPS (Diluted) | $-2.20 | $-2.92 | $-21.97 | $-2.61 |
Total Assets | $2.97M | $2.75M | $8.26M | $64.94M |
Total Liabilities | $813.00K | $692.00K | $1.96M | $26.38M |
Cash & Equivalents | $1.39M | $1.09M | $6.06M | $39.06M |
Free Cash Flow OCF − CapEx | $-2.97M | $-4.97M | $-30.34M | $-29.45M |
Shares Outstanding | 2.35M | 1.60M | 1.60M | 16.03M |